New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 11, 2014
06:28 EDTMYGNJudge denies Myriad Genetics request for injunction against rival, NY Times says
Myriad Genetics' request for a preliminary injunction against a competing company, Ambry Genetics, was denied by a federal judge, according to The New York Times. The injunction would have immediately prevented Ambry from offering a genetic test similar to the one provided by Myriad, the newspaper stated..Myriad's test determines whether individuals have two gene mutations that indicate a much higher risk of developing breast cancer. Reference Link
News For MYGN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 11, 2015
14:20 EDTMYGNWilliam Blair diagnostic services analyst holds analyst/industry conference call
Analysts, along with Dr. Todd Cohen, provide an industry update on an Analyst/Industry conference call to be held on April 16 at 3 pm.
April 8, 2015
08:45 EDTMYGNLife Sciences group well positioned heading into Q1 earnings, says Cowen
Cowen said the Life Sciences sector looks well positioned heading into Q1 earnings despite the group outperforming the broader market recently. The firm believes headwinds have intensified and multiples have stretched, but they see the downside risk as limited with upside risk dependent on improving end-market commentary, new products and milestones, and new details on capital deployment. Stocks in the space include Affymetrix (AFFX), Fluidigm (FLDM), GenMark (GNMK), Myriad Genetics (MYGN) and Quidel (QDEL).

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use